Recently Priced IPO Calendar
Company Name Ticker Offer Date Underwriter Shares IPO Price Closing Price Return Today's Price/Change
Neff NEFF 11/20/14 Morgan Stanl 10.5 $15.00 $15.00 0.0% $15.00 0.00 (0.0%)
$15.00
Peak Resorts SKIS 11/20/14 FBR Capital 10.0 $9.00 $8.64 -4.0% $8.64 0.00 (0.0%)
$8.64
Cnova CNV 11/19/14 Morgan Stanl 26.8 $7.00 $7.38 5.4% $7.38 0.00 (0.0%)
$7.38
Neothetics NEOT 11/19/14 Piper Jaffra 4.7 $14.00 $11.13 -20.5% $11.13 0.00 (0.0%)
$11.13
The Habit Restaurants HABT 11/19/14 Piper Jaffra 5.0 $18.00 $29.95 66.4% $29.95 0.00 (0.0%)
$29.95
Paramount Group PGRE 11/18/14 BofA Merrill 131.0 $17.50 $18.79 7.4% $18.79 0.00 (0.0%)
$18.79
Second Sight Medical EYES 11/18/14 MDB Capital 3.5 $9.00 $17.91 99.0% $17.91 0.00 (0.0%)
$17.91
eHi Car Services EHIC 11/17/14 J.P. Morgan 10.0 $12.00 $12.00 0.0% $12.00 0.00 (0.0%)
$12.00
STORE Capital STOR 11/17/14 Goldman Sach 27.5 $18.50 $20.00 8.1% $20.00 0.00 (0.0%)
$20.00
FibroGen FGEN 11/13/14 Goldman Sach 8.1 $18.00 $23.61 31.2% $23.61 0.00 (0.0%)
$23.61
Landmark Infrastructure LMRK 11/13/14 Baird 2.7 $19.00 $19.00 0.0% $19.00 0.00 (0.0%)
$19.00
Navios Midstream LP NAP 11/13/14 BofA Merrill 8.1 $15.00 $13.48 -10.1% $13.48 0.00 (0.0%)
$13.48
NeuroDerm NDRM 11/13/14 Jefferies & 4.5 $10.00 $7.15 -28.5% $7.15 0.00 (0.0%)
$7.15
Sky Solar Holdings SKYS 11/13/14 Roth Capital 5.5 $8.00 $10.44 30.5% $10.44 0.00 (0.0%)
$10.44
Virgin America VA 11/13/14 Barclays 13.3 $23.00 $35.41 54.0% $35.41 0.00 (0.0%)
$35.41
PRA Health Sciences PRAH 11/12/14 Jefferies & 17.0 $18.00 $22.49 24.9% $22.49 0.00 (0.0%)
$22.49
Axalta Coating AXTA 11/11/14 Citi 50.0 $19.50 $22.99 17.9% $22.99 0.00 (0.0%)
$22.99
The Joint JYNT 11/10/14 Roth Capital 3.0 $6.50 $6.32 -2.8% $6.32 0.00 (0.0%)
$6.32
Coherus BioSciences CHRS 11/06/14 J.P. Morgan 6.3 $13.50 $13.75 1.9% $13.75 0.00 (0.0%)
$13.75
Freshpet FRPT 11/06/14 Goldman Sach 10.4 $15.00 $17.80 18.7% $17.80 0.00 (0.0%)
$17.80
INC Research INCR 11/06/14 Goldman Sach 8.1 $18.50 $23.96 29.5% $23.96 0.00 (0.0%)
$23.96
Triumph Bancorp TBK 11/06/14 Sandler O'Ne 6.7 $12.00 $14.73 22.8% $14.73 0.00 (0.0%)
$14.73
Nevro NVRO 11/05/14 J.P. Morgan 7.0 $18.00 $27.51 52.8% $27.51 0.00 (0.0%)
$27.51
Upland Software UPLD 11/05/14 William Blai 3.8 $12.00 $11.60 -3.3% $11.60 0.00 (0.0%)
$11.60
Antero Midstream Partners AM 11/04/14 Barclays 40.0 $25.00 $27.97 11.9% $27.97 0.00 (0.0%)
$27.97
Xenon Pharmaceuticals XENE 11/04/14 Jefferies & 4.0 $9.00 $12.68 40.9% $12.68 0.00 (0.0%)
$12.68
Boot Barn Holdings BOOT 10/29/14 J.P. Morgan 5.0 $16.00 $21.37 33.6% $21.37 0.00 (0.0%)
$21.37
Fifth Street FSAM 10/29/14 Morgan Stanl 6.0 $17.00 $14.72 -13.4% $14.72 0.00 (0.0%)
$14.72
Shell Midstream Partners SHLX 10/28/14 Barclays 40.0 $23.00 $38.20 66.1% $38.20 0.00 (0.0%)
$38.20
Sientra SIEN 10/28/14 Piper Jaffra 5.0 $15.00 $17.62 17.5% $17.62 0.00 (0.0%)
$17.62
Anchor BanCorp Wisconsin ABCW 10/21/14 Sandler O'Ne 0.4 $26.00 $30.00 15.4% $30.00 0.00 (0.0%)
$30.00
DBV Technologies DBVT 10/21/14 Citi 4.3 $21.64 $25.51 17.9% $25.51 0.00 (0.0%)
$25.51
Proteon Therapeutics PRTO 10/21/14 Stifel 6.1 $10.00 $10.41 4.1% $10.41 0.00 (0.0%)
$10.41
Zayo Group Holdings ZAYO 10/16/14 Morgan Stanl 21.1 $19.00 $25.54 34.4% $25.54 0.00 (0.0%)
$25.54
Atara Biotherapeutics ATRA 10/15/14 Goldman Sach 5.0 $11.00 $25.89 135.4% $25.89 0.00 (0.0%)
$25.89
Dominion Midstream DM 10/14/14 Barclays 17.5 $21.00 $31.60 50.5% $31.60 0.00 (0.0%)
$31.60
Forward Pharma FWP 10/14/14 Leerink Par 10.5 $21.00 $19.90 -5.2% $19.90 0.00 (0.0%)
$19.90
Great Western Bancorp GWB 10/14/14 Deutsche Ban 16.0 $18.00 $22.15 23.1% $22.15 0.00 (0.0%)
$22.15
Dave & Busters PLAY 10/09/14 Jefferies & 5.9 $16.00 $21.49 34.3% $21.49 0.00 (0.0%)
$21.49
Diplomat Pharmacy DPLO 10/09/14 Credit Suiss 13.3 $13.00 $27.80 113.8% $27.80 0.00 (0.0%)
$27.80
HubSpot HUBS 10/08/14 Morgan Stanl 5.0 $25.00 $35.80 43.2% $35.80 0.00 (0.0%)
$35.80
MOL Global MOLG 10/08/14 Citi 13.5 $12.50 $0.00 -100.0% $0.00 0.00 (n/a)
$0.00
OM Asset Management OMAM 10/08/14 BofA Merrill 22.0 $14.00 $15.50 10.7% $15.50 0.00 (0.0%)
$15.50
USD Partners LP USDP 10/08/14 Citi 9.1 $17.00 $16.45 -3.2% $16.45 0.00 (0.0%)
$16.45
Veritex Holdings VBTX 10/08/14 Sandler O'Ne 2.7 $13.00 $16.22 24.8% $16.22 0.00 (0.0%)
$16.22
Dermira DERM 10/02/14 Citi 7.8 $16.00 $17.00 6.3% $17.00 0.00 (0.0%)
$17.00
Fairmount Santrol FMSA 10/02/14 Morgan Stanl 25.0 $16.00 $12.81 -19.9% $12.81 0.00 (0.0%)
$12.81
Yodlee YDLE 10/02/14 Goldman Sach 6.3 $12.00 $12.27 2.3% $12.27 0.00 (0.0%)
$12.27
American Addiction AAC 10/01/14 William Blai 5.0 $15.00 $28.44 89.6% $28.44 0.00 (0.0%)
$28.44
Atento ATTO 10/01/14 Morgan Stanl 10.0 $15.00 $11.24 -25.1% $11.24 0.00 (0.0%)
$11.24
Calithera Biosciences CALA 10/01/14 Citi 8.0 $10.00 $10.12 1.2% $10.12 0.00 (0.0%)
$10.12
JP Energy Partners LP JPEP 10/01/14 Barclays 13.8 $20.00 $16.65 -16.8% $16.65 0.00 (0.0%)
$16.65
VWR VWR 10/01/14 BofA Merrill 25.5 $21.00 $25.81 22.9% $25.81 0.00 (0.0%)
$25.81
Wayfair W 10/01/14 Goldman Sach 11.0 $29.00 $23.27 -19.8% $23.27 0.00 (0.0%)
$23.27
Vascular Biogenics VBLT 09/30/14 Deutsche Ban 6.7 $6.00 $6.28 4.7% $6.28 0.00 (0.0%)
$6.28
Vivint Solar VSLR 09/30/14 Goldman Sach 20.6 $16.00 $10.67 -33.3% $10.67 0.00 (0.0%)
$10.67
Please note this list only includes recently priced IPOs. For a more in-depth historical list, please inquire about our institutional research service.
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The Renaissance International IPO Index® (IPOXUS) is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO", the Renaissance International IPO ETF, symbol "IPOS" (the “ETFs”), and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the “Funds”) invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.